Results 21 to 30 of about 35,995 (160)

Is Adenosine Deaminase in Pleural Fluid a Useful Marker for Differentiating Tuberculosis from Lung Cancer or Mesothelioma in Japan, a Country with Intermediate Incidence of Tuberculosis? [PDF]

open access: yes, 2011
The objective of this study was to evaluate the utility of the determination of adenosine deaminase (ADA) level in pleural fluid for the differential diagnosis between tuberculous pleural effusion (TPE) and malignant pleural effusion (MPE) in Japan, a ...
Aoe, Keisuke   +9 more
core   +1 more source

Early Contrast Enhancement: a novel Magnetic Resonance Imaging biomarker of pleural malignancy [PDF]

open access: yes, 2018
Introduction: Pleural Malignancy (PM) is often occult on subjective radiological assessment. We sought to define a novel, semi-objective Magnetic Resonance Imaging (MRI) biomarker of PM, targeted to increased tumour microvessel density (MVD) and ...
Alexander, Laura   +10 more
core   +1 more source

Associations between EP-like lesions and pleuritis and post trimming carcass weights of finishing pigs in England [PDF]

open access: yes, 2017
Herd health slaughter checks regularly identify enzootic pneumonia-like (EP-like) lesions and pleuritis. The aim of this paper is to determine the associations between these lesions and post-trimming carcass weight.
Brewster, V R   +3 more
core   +1 more source

Model applications of decision support systems in meat hygiene programs : a thesis presented in partial fulfilment of the requirements for the degree of Master of Veterinary Science at Massey University [PDF]

open access: yes, 1996
Current systems to ensure safety of meat are to a large degree based on a "procedural" approach which specifies what inspection actions will be taken to protect human health.
Logt, Petrus Bernardus van der
core  

Pig farmers’ perceptions, attitudes, influences and management of information in the decision-making process for disease control [PDF]

open access: yes, 2014
The objectives of this study were (1) to explore the factors involved in the decision-making process used by pig farmers for disease control and (2) to investigate pig farmers’ attitudes and perceptions about different information sources relating to ...
Ajzen   +31 more
core   +3 more sources

Investigating the Spillover Mechanisms of Payment Incentives on the Outcomes for Non‐Targeted Patients

open access: yesHealth Economics, EarlyView.
ABSTRACT Payment reforms in healthcare can have spillover effects on the care experienced by non‐targeted patients treated by the same provider. Few empirical studies have quantitatively investigated the mechanisms behind these effects. We formulate theory‐driven hypotheses to investigate the spillover mechanisms of a regional payment reform in the ...
Philip Britteon   +4 more
wiley   +1 more source

In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement [PDF]

open access: yes, 2011
Background Outcomes for hospitalized patients with tuberculous pleurisy (TP) have rarely been reported, and whether or not pulmonary involvement affects outcomes is uncertain.
A Gopi   +26 more
core   +3 more sources

The Treatment of Tuberculous Pleurisy [PDF]

open access: yesThe American Journal of the Medical Sciences, 1894
n ...
openaire   +2 more sources

Risk Factors and Clinical Features of Deterioration in 739 COVID‐19 Affected Children Aged Under 14 Years in Zhuhai, China: A Multicenter, Retrospective Study

open access: yesPediatric Discovery, EarlyView.
Seven hundred and thirty‐nine children infected with SARS‐CoV‐2 in Zhuhai tend to have close‐contact aggregated morbidity within the family, with fever and cough as the main manifestations. Low age, underlying disease, some laboratory indicators, and patchy exudative changes on CT of the lungs are the windsocks of the severity of the infection ...
Ting Liu   +7 more
wiley   +1 more source

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

open access: yesAllergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy